An Open-Label, Randomized, Two-Period, Crossover Study to Characterize the Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls.
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 10 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 14 Jun 2010 Planned end date changed from 1 Oct 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov record.
- 02 Jul 2009 New trial record